JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Tel: +1-832-696-8203
Email: [email protected]
Worldwide Distributors
In vitro transcription of capped mRNA with modified nucleotides and Poly(A) tail
TSA (Tyramide Signal Amplification), used for signal amplification of ISH, IHC and IC etc.
Separation of phosphorylated and non-phosphorylated proteins without phospho-specific antibody
A convenient and sensitive way for cell proliferation assay and cytotoxicity assay
Protect the integrity of proteins from multiple proteases and phosphatases for different applications.
(+)-MK 801 is a potent antagonist of NMDA with Ki value of 30.5nM [1].
MK 801 is a potent anticonvulsant exhibits both anxiolytic and sympathomimetic properties. It is found to be a noncompetitive antagonist of NMDA. MK 801 can penetrate into the central nervous system. In the in vitro assay, MK 801 binds to rat cerebral cortical membrane with high affinity in a saturable manner. This binding is reversible even when the concentration of MK 801 is up to 100μM. It is also found that the binding shows a regional specificity. Most of these binding sites are located in the hippocampus. In rat cortical-slice preparations, MK 801 causes a potent blockade of depolarizing responses to NMDA with a high selectivity. This effect is persistent. The blockade can also cause a suppression of the epileptiform activity induced by tetrodotoxin or other neurotoxin [1].
References:[1] Wong EH, Kemp JA, Priestley T, Knight AR, Woodruff GN, Iversen LL . The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci U S A. 1986 Sep;83(18):7104-8.
Cell lines
Primary mixed neuronal/glial cultures from fetal rat brains.
Preparation method
The solubility of this compound in DMSO is >16.9mg/mL. General tips for obtaining a higher concentration: Please warm the tube at 37℃ for 10 minutes and/or shake it in the ultrasonic bath for a while. Stock solution can be stored below -20℃ for several months.
Reacting condition
10 μM for 30 minutes
Applications
NMDA induced apoptosis in mixed neuronal/glial cell cultures. In the presence of a mild excitotoxic insult, this investigation showed an attenuation of apoptotic cell death by MK 801.
Animal models
C57BL/6; BALB/c mice
Dosage form
s.c. or i.p., 0.1 mg kg(-1)
Application
MK 801 in the chronically C57BL/6 chronic stress group that prevented weight gain deficit. For the C57BL/6 strain chronic MK 801 produced an alteration of the fur state. In the CA1 layer of chronically stressed C57BL/6 mice, MK 801 induced an increase of VGLUT1 immunoreactivity. For the BALB/c group, MK 801 enhanced BDNF mRNA in the chronic stress group in the DG. In the chronically stressed BALB/c mice, MK 801 prevented stressed induced VGLUT3 immunoreactivity up-regulation in the CA3 layer.
Other notes
Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal.
References:
[1]. Wise-Faberowski L,Pearlstein RD,Warner DS., et al. NMDA-induced apoptosis in mixed neuronal/glial cortical cell cultures: the effects of isoflurane and dizocilpine. J Neurosurg Anesthesiol.2006 Oct;18(4):240-6.
[2] .Farley S, Dumas S, El Mestikawy S ., et al. Increased expression of the Vesicular Glutamate Transporter-1 (VGLUT1) in the prefrontal cortex correlates with differential vulnerability to chronic stress in various mouse strains: effects of fluoxetine and MK-801. Neuropharmacology. 2012 Jan;62(1):503-17.
